| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V128033 | ABCA1 inducer 2 | 2451589-46-9 | ABCA1 inducer 2 is a non-lipophilic ABCA1 inducer. |
|
V3965 | Abequolixron (RGX-104) | 610318-54-2 | Abequolixron (formerly known as SB742881; RG104; SB-742881) is a novel potent and orally bioavailable liver-X nuclear hormone receptor-beta (LXR)agonist with potential immunomodulating and anticancer activities. |
|
V3966 | Abequolixron (RGX-104) HCl | 610318-03-1 | AbequolixronHCl (formerly RGX-104; SB-742881; SB742881), the hydrochloride salt ofRGX104, is a novel potent and orally bioavailable liver-X nuclear hormone receptor-beta (LXR)agonist that modulates innate immunity via transcriptional activation of the ApoE gene. |
|
V3482 | BMS-779788 | 918348-67-1 | BMS-779788 (formerlyknown as XL-652, EXEL 04286652 and BMS-788) is a novel and potentLXR (Liver X Receptors)partial agonist withIC50values of 68 nM for LXRαand 14 nM for LXRβ. |
|
V1852 | GW3965 HCl | 405911-17-3 | GW3965 (GW-3965) HCl, the hydrochloride salt ofGW3965, is a novel, potent, selective LXR (liver X receptor) agonist for hLXRα and hLXRβ with potential anti-inflammatory activity. |
|
V2912 | LXR623 | 875787-07-8 | LXR623 (WAY-252623; LXR-623) is a novel, highly brain-penetrant, selective and orally bioavailable synthetic modulator of LXR (Liver X receptor) with anticancer activity, It is a partial LXRα and full LXRβ agonist with IC50s of 24 nM and 179 nM, respectively. |
|
V139144 | LXRβ ligand 1 | 171049-41-5 | LXRβ ligand 1 is an LXRβ ligand-binding domain agonist with an EC50 of 57 μM and a Ki of 28 μM for human LXRβ. |
|
V1854 | SR9243 | 1613028-81-1 | SR9243 (SR-9243) is a potent and selective inverse agonist ofLXR. |
|
V1853 | T0901317 (T-1317) | 293754-55-9 | T0901317 (formerly known as T-1317 or TO-091317 or TO 901317)is a potentand selective liver X receptor (LXR) agonist for multiple targets, which has EC50 values of 20 nM and 5 μM for LXRα and FXR, respectively. |
|
V145953 | TFCA | 895700-18-2 | TFCA is a liver X receptor α (LXRα) antagonist. |
|
V146154 | TLC-2716 | TLC-2716 is an orally effective intestinal and liver-targeting LXRα and LXRβ inhibitor with EC50 values of 7 nM and 15 nM, respectively. | |
|
V60091 | Iristectorigenin B | 86849-77-6 | Iristectorigenin B (Iristectrigenin B) is a liver X receptor (LXR) modulator. |